Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001209191-22-002753

Chief Medical Officer bought 1,700 shares at $4.80 ($8,168)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Whiting Samuel Chief Medical Officer 2022-01-06 Purchase +1,700 $4.80 $8,168 1,901 D
Open-market purchases · 1,700 sh · avg $4.80 · $8,168
Loading xslF345X03/doc4.xml…